Skip to main content
SpringerLink
Log in

Recurrent ocular disease in congenital toxoplasmosis: clinical manifestations

  • Conference paper
Congenital toxoplasmosis

  • 372 Accesses

Abstract

Ocular involvement in toxoplasmosis (of both, congenital and postnatal origins) manifests itself in the majority of patients during the late chronic stage of the infection and does not complicate the acute stage of the disease [1]. Of the congenitally infected children only a small proportion (less than 15%) have apparent ocular involvement in the (acute) perinatal period; however, long-term follow-up demonstrated that about 80% to 100% of these infected children developed late neurological and/or ocular sequelae [2–4]. This indicates that congenitally infected children, including those with subclinical infections without any signs and symptoms of the disease at birth, regularly develop late ocular involvement, even after an interval of many years (most typically during the teenage years and young adulthood) [5].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Rothova A (1992) Ocular involvement in toxoplasmosis. Br J Ophthalmol 77:371–377

    Article  Google Scholar 

  2. Wilson CB, Remington JS, Stagno S, Reynold DW (1980) Development of adverse sequelae in children born with subclinical Toxoplasma infection. Pediatrics 66:767–774

    PubMed  CAS  Google Scholar 

  3. Desmonts G, Remington JS, Couvreur J (1987) Congenital toxoplasmosis. In: Stern L, Vert P (eds) Neonatal medicine. Masson Publ Comp, pp 662–678

    Google Scholar 

  4. Koppe JG, Loewer-Sieger DH, de Roever-Bonnet (1986) Results of 20year follow-up of congenital toxoplasmosis. Lancet 1:254–256

    Article  PubMed  CAS  Google Scholar 

  5. Loewer-Sieger DH, Rothova A, Koppe JG, Kijlstra A (1984) Congenital toxoplasmosis: a prospective study based on 1821 pregnant women. In: Saari KM (ed) Uveitis update. Elsevier, Amsterdam, pp 203–207

    Google Scholar 

  6. Holland G, O’Connor GR, Belfort R Jr, Remington JS (1996) Toxoplasmosis. In: Pepose JS, Holland GN, Wilhelmus KR (eds). Infectious ocular diseases. Mosby-Year Book Inc, pp 1183–1223

    Google Scholar 

  7. Nussenblatt RB, Mittal KK, Fuhrman S, Sharma SD, Palestine AG (1989) Lymphocyte proliferative responses of patients with ocular toxoplasmosis to parasite and retinal antigens. Am J Ophthalmol 107:632–641

    PubMed  CAS  Google Scholar 

  8. Wyler DJ, Blackman HJ, Lunde MN (1980) Cellular hypersensitivity to toxoplasmal and retinal antigens in patients with toxoplasmal retinochoroiditis. Am J Trop Med Hyg 29:1181–1186.

    PubMed  CAS  Google Scholar 

  9. Whittle RM, Wallace GR, Whiston RA, Dumonde DC, Stanford MR (1988) Human retinal antibodies in toxoplasma retinochoroiditis. Br J Ophthalmol 82:1017–1021

    Article  Google Scholar 

  10. Pavesio CE, Lightman S (1996) Toxoplasma gondii and ocular toxoplasmosis: pathogenesis. Br J Ophthalmol 80:1099–1107

    Article  PubMed  CAS  Google Scholar 

  11. Rao NA, Font RL (1997) Toxoplasmic retinochoroiditis: electron microscopic and immunofluorescence studies of formalin-fixed tissue. Arch Ophthalmol 95:273–277

    Article  Google Scholar 

  12. O’Connor GR (1983) Factors related to initiation and recurrence of uveitis. Am J Ophthalmol 96:577–599

    PubMed  Google Scholar 

  13. Meenken C, Rothova A, de Waal LP, van der Horst AR, Mesman BJ, Kijlstra A (1995) HLA typing in congenital toxoplasmosis. Br J Ophthalmol 79:494–497

    Article  PubMed  CAS  Google Scholar 

  14. Smith JE, McNeil G, Zhang YIN, Dutton S, Biswas-Hughes G, Appleford P (1996) Serological recognition of Toxoplasma gondii cyst antigens. In: Gross U (ed). Toxoplasma gondii. Springer-Verlag Berlin Heidelberg, pp 67–73

    Google Scholar 

  15. Rothova A, van Knapen F, Baarsma GS, Kruit PJ, Loewer-Sieger DH, Kijlstra A (1986) Serology in ocular toxoplasmosis. Br J Ophthalmol 70:615–22

    Article  PubMed  CAS  Google Scholar 

  16. Peyron F, Wallon M, Bernardoux C (1996) Long-term follow-up of patients with congenital ocular toxoplasmosis N Eng J Med 334:993–994

    CAS  Google Scholar 

  17. Rothova A, Meenken C, Buitenhuis HJ et al (1993) Therapy for ocular toxoplasmosis. Am J Ophthalmol 115:517–523

    PubMed  CAS  Google Scholar 

  18. Couvreur J, Nottin N, Desmonts G (1980) La toxoplasmose congénitale traitée. Annales de Pédiatrie 27:647–652

    PubMed  CAS  Google Scholar 

  19. Mets MB, Holfels E, Boyer KM, Swisher CN, Roizen N, Stein L, Stein M, Hopkins J, Withers S, Mack D, Luciano R, Patel D, Remington JS, Meier P, McLeod R (1997) Eye manifestations of congenital toxoplasmosis. Am J Ophthalmol 123:1–16

    PubMed  CAS  Google Scholar 

  20. Bernasconi O, Auer C, Herbort CP (1997) Recurrent toxoplasmic retinochoroiditis. Significance of perilesional satellite dark dots seen by indocyanine green angiography. Ocul Immunol Inflamm 5:207–211

    CAS  Google Scholar 

  21. Holland GN, Engstrom RE, Glasgow BJ et al (1998) Ocular toxoplasmosis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol 106:653–667

    Google Scholar 

  22. Peacock JE Jr, Greven CM, Cruz JM, Hurd DD (1995) Reactivation of toxoplasmic retinochoroiditis in patients undergoing bone marrow transplantation: is there a role for chemoprophylaxis? Bone Marrow Transplant 15:983–987

    PubMed  Google Scholar 

  23. Bosch-Driessen EH, Rothova A (1998) Sense and nonsense of corticosteroid administration in the treatment of ocular toxoplasmosis. Br J Ophthalmol 82:858–860

    Article  PubMed  CAS  Google Scholar 

  24. Morhun PJ, Weisz JM, Elias SJ, Holland GN (1996) Recurrent ocular toxoplasmosis in patients treated with systemic corticosteroids. Retina 16:383–387

    Article  PubMed  CAS  Google Scholar 

  25. Theodossiadis P, Kokolakis S, Ladas I, Kollia AC, Chatzoulis D, Theodossiadis G (1995) Retinal vascular involvement in acute toxoplasmic retinochoroiditis. Int Ophthalmol 19:19–24

    Article  PubMed  CAS  Google Scholar 

  26. Iijima H, Tsukahara Y, Imasawa M (1995) Angiographic findings in eyes with active ocular toxoplasmosis. Jpn J Ophthalmol 39:402–410

    PubMed  CAS  Google Scholar 

  27. Auer C, Bernasconi O, Herbort CP (1997) Toxoplasmic retinochoroiditis: new insights provided by indocyanine green angiography. Am J Ophthalmol 123:131–133

    PubMed  CAS  Google Scholar 

  28. Rehder JR, Burnier M, Pavesio CE et al (1988) Acute unilateral toxoplasmic iridocyclitis in an AIDS patient. Am J Ophthalmol 106:740–741

    PubMed  CAS  Google Scholar 

  29. Fish RH, Hoskins JC, Kline LB (1993) Toxoplasmosis neuroretinitis. Ophthalmology 100:1177–1182

    Article  PubMed  CAS  Google Scholar 

  30. Tandon R, Menon V, Das GK, Verma L (1995) Toxoplasmic papillitis with central retinal artery occlusion. Can J Ophthalmol 30:374–376

    PubMed  CAS  Google Scholar 

  31. Friedman CT, Knox DL (1969) Variations in recurrent active toxoplasmic retinochoroiditis. Arch Ophthalmol 81:481–493

    Article  Google Scholar 

  32. Bosch-Driessen EH, Stilma JS, Karimi S, Rothova A (1999) Retinal detachment in ocular toxoplasmosis. (Submitted manuscript)

    Google Scholar 

  33. De Jong PTVM (1997) Ocular toxoplasmosis; common and rare symptoms and signs. Int Ophthalmol 13:391–397

    Article  Google Scholar 

  34. Meenken C, Assies J, van Nieuwenhuizen O, Holwerda-van der Maat WG, van Schooneveld MJ, Delleman WJ, Kinds G, Rothova A (1995) Long term ocular and neurological involvement in severe congenital toxoplasmosis. Br J Ophthalmol 79:581–584

    Article  PubMed  CAS  Google Scholar 

  35. Schwab IR (1991) The epidemiologic association of Fuchs’ heterochromic iridocyclitis and ocular toxoplasmosis. Am J Ophthalmol 111:356–362

    PubMed  CAS  Google Scholar 

  36. La Heij E, Rothova A (1991) Fuchs’s heterochromic cyclitis in congenital ocular toxoplasmosis. Br J Ophthalmo175:372–373

    Article  Google Scholar 

  37. Silveira C, Belfort R Jr, Nussenblatt R et al (1989) Unilateral pigmentary retinopathy associated with ocular toxoplasmosis. Am J Ophthalmo1107:682–683

    Google Scholar 

  38. De Boer JH, Verhagen C, Bruinenberg M, Rothova A, De Jong PTVM, Baarsma GS, Lelij van der A, Ooyman FM, Bollemeijer JG, Derhaag PJFM, Kijlstra A (1996) Serologic and Polymerase Chain Reaction Analysis of Intraocular Fluids in the Diagnosis of Infectious Uveitis. Am J Ophthalmol 121:650–658

    PubMed  Google Scholar 

  39. Khalifa el KS, Roth A, Roth B, Arasteh KN, Janitschke K (1994) Value of PCR for evaluating occurrence of parasitemia in immunocompromised patients with cerebral and extracerebral toxoplasmosis. J Clin Microbiol 32:2813–2819

    Google Scholar 

  40. Garweg J, Boehnke M, Koerner F (1996) Restricted applicability of the polymerase chain reaction for the diagnosis of ocular toxoplasmosis. Ger J Ophthalmol 5:104–108

    PubMed  CAS  Google Scholar 

  41. Aouizerate F, Cazenave J, Poirier L, Verin P, Cheyrou A, Begueret J, Lagoutte F (1993) Detection of Toxoplasma gondii in aqueous humour by the polymerase chain reaction. Br J Ophthalmol 77:107–109

    Article  PubMed  CAS  Google Scholar 

  42. Lam S, Tessler HH (1993) Quadruple therapy for ocular toxoplasmosis. Can J Ophthalmol 28:58–61

    PubMed  CAS  Google Scholar 

  43. Engstrom RE, Holland GN, Nussenblatt RB, Jabs DA (1991) Current practices in the management of ocular toxoplasmosis. Am J Ophthalmol 111:601–610

    PubMed  Google Scholar 

  44. Huskinson-Mark J, Araujo FG, Remington JS (1991) Evaluation of the effect of drugs on the cyst form of toxoplasma gondii. J Infect Dis 164:170–177

    Article  PubMed  CAS  Google Scholar 

  45. Gormley PD, Pavesio CE, Minnasian D, Lightman S (1998) Effects of drug therapy on Toxoplasma cysts in an animal model of acute and chronic disease. Invest Ophthalmol Vis Sci 39:1171–1175

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. A. Rothova
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Faculté de Médecine de Grenoble, Université Joseph Fourier, Grenoble, France

    Pierre Ambroise-Thomas

  2. Statenserum Institut, Copenhagen, Denmark

    Peter Eskild Petersen

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag France

About this paper

Cite this paper

Rothova, A. (2000). Recurrent ocular disease in congenital toxoplasmosis: clinical manifestations. In: Ambroise-Thomas, P., Petersen, P.E. (eds) Congenital toxoplasmosis. Springer, Paris. https://doi.org/10.1007/978-2-8178-0847-5_16

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0847-5_16

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-59664-3

  • Online ISBN: 978-2-8178-0847-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation